These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial. Arai S; Meagher R; Swearingen M; Myint H; Rich E; Martinson J; Klingemann H Cytotherapy; 2008; 10(6):625-32. PubMed ID: 18836917 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy. Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094 [TBL] [Abstract][Full Text] [Related]
14. A phase I trial of CD3/CD28-activated T cells (Xcellerated T cells) and interleukin-2 in patients with metastatic renal cell carcinoma. Thompson JA; Figlin RA; Sifri-Steele C; Berenson RJ; Frohlich MW Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3562-70. PubMed ID: 14506142 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study. Mordoh J; Kairiyama C; Bover L; Solarolo E Medicina (B Aires); 1997; 57(4):421-7. PubMed ID: 9674264 [TBL] [Abstract][Full Text] [Related]
16. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma? Kwak C; Park YH; Jeong CW; Lee SE; Ku JH Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297 [TBL] [Abstract][Full Text] [Related]
17. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma. Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071 [TBL] [Abstract][Full Text] [Related]
18. Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients. Atzpodien J; Morawek L; Fluck M; Reitz M Cancer Chemother Pharmacol; 2009 Oct; 64(5):901-5. PubMed ID: 19229537 [TBL] [Abstract][Full Text] [Related]
19. Randomized phase II study of IL-2 with or without an allogeneic large multivalent immunogen vaccine for the treatment of stage IV melanoma. Jha G; Miller JS; Curtsinger JM; Zhang Y; Mescher MF; Dudek AZ Am J Clin Oncol; 2014 Jun; 37(3):261-5. PubMed ID: 23241505 [TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II study of chemo-immunotherapy in the treatment of metastatic renal cell carcinoma. Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Necozione S; Fumagalli L; Rea S J Immunother; 2007; 30(4):448-54. PubMed ID: 17457219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]